Integer (NYSE:ITGR – Get Free Report) and Nexeon Medsystems (OTCMKTS:NXNN – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, profitability, risk, institutional ownership and analyst recommendations. Analyst Ratings This is a breakdown of current ratings […]
Integer (NYSE:ITGR – Get Free Report) and Nexeon Medsystems (OTCMKTS:NXNN – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk and institutional ownership. Analyst Recommendations This is a summary of recent ratings […]
Integer (NYSE:ITGR – Get Free Report) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 5.010-5.430 for the period, compared to the consensus EPS estimate of 5.310. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion. Integer also updated its FY24 […]
Integer (NYSE:ITGR – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Benchmark in a research note issued on Friday, Benzinga reports. They presently have a $130.00 target price on the medical equipment provider’s stock. Benchmark’s price target indicates a potential upside of 19.74% from the stock’s current price. Other analysts […]
Integer (NYSE:ITGR – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Benchmark in a research note issued to investors on Friday, Benzinga reports. They currently have a $130.00 price target on the medical equipment provider’s stock. Benchmark’s target price points to a potential upside of 19.74% from the company’s previous […]